Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethnic Differences in Anti-Hypertensive Response in Pregnancy
NCT03506724Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nifedipine GITS and labetalol in gestational hypertension (GH) and preeclampsia (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoints: Time to Achieve Non Severe Range Blood Pressure at 1 hour and Number of Participants to Achieve Non Severe Range Blood Pressure at 1 hour. Started Sep 2017; status: completed.
02
Drugs
nifedipine GITSlabetalol
03
Conditions
gestational hypertension (GH)preeclampsia
Beyond the preview
Go deeper on NCT03506724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03506724.